Tag: bioequivalence
Cmax and AUC in Bioequivalence: What Peak Concentration and Total Exposure Really Mean
30 Dec
|
12:05 PM
Cmax and AUC are the two key pharmacokinetic measures used to prove generic drugs work the same as brand-name versions. Cmax shows peak concentration, while AUC measures total exposure. Both must fall within 80%-125% of the original for approval.
read more
Generic Drug Approval Standards: Safety, Quality, and Strength Requirements
29 Dec
|
12:58 PM
Generic drugs must meet the same safety, quality, and strength standards as brand-name drugs. The FDA ensures this through strict bioequivalence testing, manufacturing inspections, and rigorous review of every application before approval.
read more